Search Results - "Eissler, N."
-
1
Body surface area-based omega-3 fatty acids supplementation strongly correlates to blood concentrations in children
Published in Prostaglandins, leukotrienes and essential fatty acids (01-06-2021)“…•Omega-3-dose adjusted to BSA strongly correlated to blood omega-3 concentrations.•Results suggest a supplementation dose of 1500 mg/m2 BSA for further…”
Get full text
Journal Article -
2
Combination Therapy of Anti-PD-1 Antibody and CSF-1R Inhibitor Reverses Induction of Suppressive Myeloid Cells and Controls Spontaneous Neuroblastoma Progression
Published in PEDIATRIC BLOOD & CANCER (2016)Get full text
Journal Article Conference Proceeding -
3
Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma
Published in Clinical cancer research (01-08-2016)“…Neuroblastoma is the most common extracranial solid cancer type in childhood, and high-risk patients have poor prognosis despite aggressive multimodal…”
Get full text
Journal Article -
4
The role of immune semaphorins in cancer progression
Published in Experimental Cell Research (01-07-2013)“…•SEMA3A restricts tumor progression while SEMA4D induce tumor progression.•Tumor angiogenesis is induced by SEMA4D but inhibited by SEMA3A.•T-cells are…”
Get full text
Journal Article Book Review -
5
Inhibition of Microsomal Prostaglandin E Synthase-1 in Cancer-Associated Fibroblasts Suppresses Neuroblastoma Tumor Growth
Published in EBioMedicine (01-06-2018)“…Despite recent progress in diagnosis and treatment, survival for children with high-risk metastatic neuroblastoma is still poor. Prostaglandin E2 (PGE2)-driven…”
Get full text
Journal Article -
6
Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade
Published in Oncoimmunology (01-01-2016)“…Removal of immuno-suppression has been reported to enhance antitumor immunity primed by checkpoint inhibitors. Although PD-1 blockade failed to control tumor…”
Get full text
Journal Article -
7
PPM1D Is a Therapeutic Target in Childhood Neural Tumors
Published in Cancers (30-11-2021)“…Childhood medulloblastoma and high-risk neuroblastoma frequently present with segmental gain of chromosome 17q corresponding to aggressive tumors and poor…”
Get full text
Journal Article -
8
Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy
Published in Biomedicines (01-05-2024)“…Human epidermal growth factor receptor 2 (HER2) is a major prognostic and predictive marker overexpressed in 15-20% of breast cancers. The diagnostic reference…”
Get full text
Journal Article -
9
Omegachild - An Early Clinical Study Aiming at a Novel Approach to Treat Neural Tumors and Prevent Long-Term Side Effects
Published in PEDIATRIC BLOOD & CANCER (2017)Get full text
Conference Proceeding -
10
NEUROBLASTOMA IMMUNOTHERAPY TARGETING CSF-1R REVERSES INDUCTION OF SUPPRESSIVE MYELOID CELLS AND CONTROLS AGGRESSIVE TUMOR PROGRESSION
Published in PEDIATRIC BLOOD & CANCER (2015)Get full text
Conference Proceeding -
11
A best in class anti-CD38 antibody with antitumor and immune-modulatory properties
Published in CANCER RESEARCH (2018)Get full text
Conference Proceeding -
12
-
13
The PPM1D encoded phosphatase Wip1 is a novel oncogene and potential therapeutic target in neuroblastoma and medulloblastoma
Published in CANCER RESEARCH (2015)Get full text
Conference Proceeding -
14
THE PPM1D ENCODED PHOSPHATASE WIP1 IS A NOVEL ONCOGENE AND POTENTIAL THERAPEUTIC TARGET IN NEUROBLASTOMA AND MEDULLOBLASTOMA
Published in PEDIATRIC BLOOD & CANCER (2015)Get full text
Conference Proceeding